Proposed Data Collection Submitted for Public Comment and Recommendations, 20160-20161 [2021-07840]
Download as PDF
<![CDATA[
20160
Federal Register / Vol. 86, No. 72 / Friday, April 16, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
Regulatory Secretariat Division will be
submitting to the Office of Management
and Budget (OMB) a request to review
and approve an extension of a
previously approved information
collection requirement of GSA Form
1142, Release of Claims, regarding final
payment under construction and
building services contract.
DATES: Submit comments on or before:
June 15, 2021.
ADDRESSES: Submit comments regarding
this burden estimate or any other aspect
of this collection of information,
including suggestions for reducing this
burden to: https://www.regulations.gov.
Submit comments via the Federal
eRulemaking portal by searching for
Information Collection 3090–0080.
Select the link ‘‘Comment Now’’ that
corresponds with ‘‘Information
Collection 3090–0080, Contract
Financing Final Payment; GSA Form
1142, Release of Claims’’. Follow the
instructions provided at the ‘‘Submit a
Comment’’ screen. Please include your
name, company name (if any), and
‘‘Information Collection 3090–0080,
Contract Financing Final Payment; GSA
Form 1142, Release of Claims’’ on your
attached document. If your comment
cannot be submitted using https://
www.regulations.gov, call or email the
points of contact in the FOR FURTHER
INFORMATION CONTACT section of this
document for alternate instructions.
Instructions: Comments received
generally will be posted without change
to https://www.regulations.gov, including
any personal and/or business
confidential information provided. To
confirm receipt of your comment(s),
please check www.regulations.gov,
approximately two-to-three days after
submission to verify posting.
FOR FURTHER INFORMATION CONTACT:
Bryon Boyer, Procurement Analyst,
Office of Governmentwide Policy, by
phone at 817–850–5580 or by email at
gsarpolicy@gsa.gov.
SUPPLEMENTARY INFORMATION:
A. Purpose
The General Services Administration
Acquisition Regulation (GSAR) clause
552.232–72 requires construction and
building services contractors to submit
a release of claims before final payment
is made to ensure contractors are paid
in accordance with their contract
requirements and for work performed.
GSA Form 1142, Release of Claims is
used to achieve uniformity and
consistency in the release of claims
process.
B. Annual Reporting Burden
Respondents: 1,330.
VerDate Sep<11>2014
19:57 Apr 15, 2021
Jkt 253001
Responses per Respondent: 1.
Annual Responses: 1,330.
Hours per Response: 0.10.
Total Burden Hours: 133.
C. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary and whether it
will have practical utility; whether our
estimate of the public burden of this
collection of information is accurate and
based on valid assumptions and
methodology; and ways to enhance the
quality, utility, and clarity of the
information to be collected.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov.
Please cite OMB Control No. 3090–
0080; Contract Financing Final
Payment, GSA Form 1142, Release of
Claims, in all correspondence.
Jeffrey A. Koses,
Senior Procurement Executive, Office of
Acquisition Policy, Office of Governmentwide Policy.
[FR Doc. 2021–07806 Filed 4–15–21; 8:45 am]
BILLING CODE 6820–61–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21EK; Docket No. CDC–2021–
0037]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled American Academy of Pediatrics
(AAP) Neurodevelopmental Extension
for Community Health Outcomes
(ECHO)program on Children with Fetal
Alcohol Spectrum Disorders (FASD).
SUMMARY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
The purpose of this information
collection is to monitor and evaluate the
American Academy of Pediatrics (AAP)
Neurodevelopmental Extension for
Community Health Outcomes (ECHO)
Program on Children with Fetal Alcohol
Spectrum Disorders (FASD). The intent
of the project is to improve practicing
pediatrician capacity for identification
and care of children with
neurodevelopmental disorders,
particularly prenatal exposure to
alcohol, in the medical home.
DATES: CDC must receive written
comments on or before June 15, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0037 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
E:\FR\FM\16APN1.SGM
16APN1
20161
Federal Register / Vol. 86, No. 72 / Friday, April 16, 2021 / Notices
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
American Academy of Pediatrics
(AAP) Neurodevelopmental Extension
inform any needed changes in topics,
procedures, or other aspects of the
program. The purpose and use of the
session evaluation data will be to assure
that specific information is conveyed
and understood by participants for each
monthly session, ongoing improvement
in identification and referral by
participating pediatricians, and to
inform subsequent neurodevelopmental
ECHO projects.
Data will be collected through secure
email and will include monthly chart
reviews, a monthly session evaluation
survey, one overall program evaluation
survey at the end of the project period,
and one overall debriefing conference
call at the end of the project. The target
population is actively practicing
pediatricians. Quantitative descriptive
analyses are planned for the chart
reviews. Qualitive data will be obtained
from the session and program
evaluation surveys, as well as the
debriefing conference call. CDC requests
approval for an estimated 496
annualized burden hours.
for Community Health Outcomes
(ECHO) Program on Children with Fetal
Alcohol Spectrum Disorders (FASD)—
New—National Center on Birth Defects
and Developmental Disabilities
(NCBDDD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The purpose of this information
collection is to monitor and evaluate the
American Academy of Pediatrics (AAP)
Neurodevelopmental Extension for
Community Health Outcomes (ECHO)
Program on Children with Fetal Alcohol
Spectrum Disorders (FASD). The intent
of the project is to improve practicing
pediatrician capacity for identification
and care of children with
neurodevelopmental disorders,
particularly prenatal exposure to
alcohol, in the medical home.
Evaluation information will be used
to monitor any incorporation of
presented materials or suggestions from
ECHO sessions into participating
pediatric practices. Feedback also will
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Pediatricians
Pediatricians
Pediatricians
Pediatricians
Number of
responses
Burden per
response
(minutes)
Burden in
hours
...............
...............
...............
...............
Chart Review ..........................................................
Session evaluation survey .....................................
Program evaluation survey ....................................
Debriefing conference call ......................................
15
15
15
15
160
8
1
1
12/60
5/60
5/60
60/60
480
10
1
15
Total .....................
.................................................................................
........................
........................
........................
496
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–07840 Filed 4–15–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21EE; Docket No. CDC–2021–
0033]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Form name
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
SUMMARY:
VerDate Sep<11>2014
19:57 Apr 15, 2021
Jkt 253001
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Integrated Viral Hepatitis
Surveillance and Prevention Funding
for Health Departments. This new data
collection is for viral hepatitis (VH) case
reporting data collected from the
National Notifiable Diseases
Surveillance System (NNDSS) which
provides the primary population-based
data used to describe the epidemiology
of VH in the United States and for
annual reporting of surveillance,
prevention, and epidemiology
performance measures via an Annual
Performance Report.
CDC must receive written
comments on or before June 15, 2021.
DATES:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
You may submit comments,
identified by Docket No. CDC–2021–
0033 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
ADDRESSES:
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 86, Number 72 (Friday, April 16, 2021)]
[Notices]
[Pages 20160-20161]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07840]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-21EK; Docket No. CDC-2021-0037]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled American Academy of Pediatrics
(AAP) Neurodevelopmental Extension for Community Health Outcomes
(ECHO)program on Children with Fetal Alcohol Spectrum Disorders (FASD).
The purpose of this information collection is to monitor and evaluate
the American Academy of Pediatrics (AAP) Neurodevelopmental Extension
for Community Health Outcomes (ECHO) Program on Children with Fetal
Alcohol Spectrum Disorders (FASD). The intent of the project is to
improve practicing pediatrician capacity for identification and care of
children with neurodevelopmental disorders, particularly prenatal
exposure to alcohol, in the medical home.
DATES: CDC must receive written comments on or before June 15, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0037 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
[[Page 20161]]
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
American Academy of Pediatrics (AAP) Neurodevelopmental Extension
for Community Health Outcomes (ECHO) Program on Children with Fetal
Alcohol Spectrum Disorders (FASD)--New--National Center on Birth
Defects and Developmental Disabilities (NCBDDD), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The purpose of this information collection is to monitor and
evaluate the American Academy of Pediatrics (AAP) Neurodevelopmental
Extension for Community Health Outcomes (ECHO) Program on Children with
Fetal Alcohol Spectrum Disorders (FASD). The intent of the project is
to improve practicing pediatrician capacity for identification and care
of children with neurodevelopmental disorders, particularly prenatal
exposure to alcohol, in the medical home.
Evaluation information will be used to monitor any incorporation of
presented materials or suggestions from ECHO sessions into
participating pediatric practices. Feedback also will inform any needed
changes in topics, procedures, or other aspects of the program. The
purpose and use of the session evaluation data will be to assure that
specific information is conveyed and understood by participants for
each monthly session, ongoing improvement in identification and
referral by participating pediatricians, and to inform subsequent
neurodevelopmental ECHO projects.
Data will be collected through secure email and will include
monthly chart reviews, a monthly session evaluation survey, one overall
program evaluation survey at the end of the project period, and one
overall debriefing conference call at the end of the project. The
target population is actively practicing pediatricians. Quantitative
descriptive analyses are planned for the chart reviews. Qualitive data
will be obtained from the session and program evaluation surveys, as
well as the debriefing conference call. CDC requests approval for an
estimated 496 annualized burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Burden per
Type of respondents Form name Number of Number of response Burden in
respondents responses (minutes) hours
----------------------------------------------------------------------------------------------------------------
Pediatricians................. Chart Review.... 15 160 12/60 480
Pediatricians................. Session 15 8 5/60 10
evaluation
survey.
Pediatricians................. Program 15 1 5/60 1
evaluation
survey.
Pediatricians................. Debriefing 15 1 60/60 15
conference call.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 496
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-07840 Filed 4-15-21; 8:45 am]
BILLING CODE 4163-18-P
